In 2023, Germany led European Value Added in Basic Pharmaceutical Products and Preparations, accounting for 26.8 billion Euros. Germany experienced a 1.89% year-on-year growth. Belgium followed with 15.78 billion Euros and an impressive 13.85% increase. Austria, Slovenia, Portugal, Croatia, Cyprus, and Lithuania showed more modest growth, with notable performances from Cyprus at 15.66% and Portugal at 7.54%. Lithuania had marginal growth at 0.68%.
Future trends to watch include:
- Increased investment in pharmaceutical R&D.
- Technological advancements driving efficiency.
- Potential regulatory changes impacting the industry landscape.
- Expansion of biopharmaceutical sectors in smaller EU countries.
Top countries in Value Added of Basic Pharmaceutical Products and Preparations by Country
| # | 8 Countries | Million Euros | Last Year | YoY | 5-years CAGR | |
|---|---|---|---|---|---|---|
| 1 | 1 Germany | 26,800 | 2023 | +1.54% | +1.89% | View data |
| 2 | 2 Belgium | 15,780 | 2023 | +7.84% | +13.85% | View data |
| 3 | 3 Austria | 2,820 | 2023 | +2.76% | +4.1% | View data |
| 4 | 4 Slovenia | 1,420 | 2023 | +3.46% | +6.14% | View data |
| 5 | 5 Portugal | 869.77 | 2023 | +6.68% | +7.54% | View data |
| 6 | 6 Croatia | 370.88 | 2023 | +0.14% | +0.12% | View data |
| 7 | 7 Cyprus | 286.12 | 2023 | +12.13% | +15.66% | View data |
| 8 | 8 Lithuania | 91.16 | 2023 | -0.89% | +0.68% | View data |
Latest reports
US Pharmaceuticals Market Report- Q4 2024
In the fourth quarter of 2024, the US pharmaceuticals market exhibited robust growth across various segments, driven by strategic investments, regulatory advancements, and...
Japan Pharmaceuticals Market Report- Q4 2024
The Japanese pharmaceutical industry in Q4 2024 exhibits dynamic shifts driven by government policies, market demand, and strategic innovations. The continuous rise of...
Germany Pharmaceuticals Market Report- Q4 2024
The fourth quarter of 2024 presented a multifaceted landscape for the German pharmaceuticals industry, characterized by economic pressures, regulatory changes, and evolving consumer...
India Pharmaceuticals Market Report- Q4 2024
The Indian pharmaceutical industry in Q4 2024 continues to show dynamic growth, fueled by advancements in biologics and biosimilars, substantial export activities, and...
UK Pharmaceuticals Market Report- Q4 2024
The UK Pharmaceuticals market in Q4 2024 faced a dynamic landscape shaped by economic, regulatory, and competitive factors. Amidst inflationary pressures and evolving...
France Pharmaceuticals Market Report- Q4 2024
The French pharmaceuticals market in the fourth quarter of 2024 was marked by significant developments across various segments, including biopharmaceuticals, generic drugs, over-the-counter...
Canada Pharmaceuticals Market Report- Q4 2024
In the fourth quarter of 2024, the Canadian pharmaceuticals market showcased dynamic growth and adaptation across various segments. The evolving landscape was influenced...
Brazil Pharmaceuticals Market Report- Q4 2024
The Brazil pharmaceuticals market in Q4 2024 is characterized by significant trends and strategic developments across various segments. The demand for generic pharmaceuticals...
Italy Pharmaceuticals Market Report- Q4 2024
The fourth quarter of 2024 presents a dynamic landscape for the pharmaceuticals market in Italy, characterized by significant trends and strategic developments across...
South Korea Pharmaceuticals Market Report- Q1 2025
The first quarter of 2025 has been pivotal for the pharmaceuticals industry in South Korea, marked by significant growth in the biopharmaceuticals and...
